Business
How Moderna went from coronavirus sequence to a phase-1-ready vaccine candidate in 42 Days – Motley Fool Australia
The biotech got a little help from Amazon’s AWS.
Moderna(NASDAQ:MRNA), one of the leaders in the race to develop a coronavirus vaccine, was able to take the initial coronavirus sequence and get a vaccine candidate, mRNA-1273, ready for a phase 1 clinical trial in just 42 days.
The biotech’s use of Amazon Web Services (AWS), the cloud-based computing service run by Amazon (NASDAQ:AMZN), enabled this quick development. Moderna runs its Drug Design Studio on AWS, which allows it to design its mRNA drug candidates quickly.
The potential drugs ar…
-
General19 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General16 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News20 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General5 hours agoByford rail extension opening marks final stage of Perth Metronet